Table of Contents

company-logo

Mabwell (Shanghai) Bioscience Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of biological products in China and internationally. The company offers its products for auto-immune, oncology, ophthalmologic, and infectious diseases, as well as metabolic disorders, etc. It offers JUNMAIKANG, an autoimmune Adalimumab injection. The company’s oncology products pipeline includes 9MW2821 and 6MW3211, which are in phase II of clinical trial; 9MW2921, 9MW3811, and 7MW3711, which are in phase I clinical trials; 9MW0321; and 8MW0511, which is in phase III clinical trial. It also develops autoimmune products, such as 9MW1911 and 9MW3811, which are in phase 1 clinical trial; metabolic products comprising MAILISHU and 9MW3011; ophthalmology candidates, including 9MW0813 and 9MW0211 that are in phase III clinical trial; and 9MW1411, an infectious product candidate. The company was founded in 2017 and is based in Shanghai, China.

Mabwell Bioscience Dividend Announcement

• Mabwell Bioscience does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Mabwell Bioscience dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Mabwell Bioscience Dividend History

Mabwell Bioscience Dividend Yield

Mabwell Bioscience current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Mabwell Bioscience stock? Use our calculator to estimate your expected dividend yield:

Mabwell Bioscience Financial Ratios

P/E ratio-8.80
PEG ratio-2.09
P/B ratio4.91
ROE-47.19%
Payout ratio-5.09%
Current ratio1.40
Quick ratio1.25
Cash Ratio1.08

Mabwell Bioscience Dividend FAQ

Does Mabwell Bioscience stock pay dividends?
Mabwell Bioscience does not currently pay dividends to its shareholders.
Has Mabwell Bioscience ever paid a dividend?
No, Mabwell Bioscience has no a history of paying dividends to its shareholders. Mabwell Bioscience is not known for its dividend payments.
Why doesn't Mabwell Bioscience pay dividends?
There are several potential reasons why Mabwell Bioscience would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Mabwell Bioscience ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Mabwell Bioscience has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Mabwell Bioscience a dividend aristocrat?
Mabwell Bioscience is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Mabwell Bioscience a dividend king?
Mabwell Bioscience is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Mabwell Bioscience a dividend stock?
No, Mabwell Bioscience is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Mabwell Bioscience stocks?
To buy Mabwell Bioscience you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Mabwell Bioscience stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.